Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 5.23M | 279.01K | 328.29K | 752.77K | 899.28K |
Gross Profit | 5.20M | 279.01K | 309.55K | 711.24K | 899.28K |
EBITDA | 2.68M | -1.41M | -4.73M | -4.02M | -1.96M |
Net Income | 2.00M | -2.05M | -5.14M | -4.08M | -2.10M |
Balance Sheet | |||||
Total Assets | 340.45K | 1.51M | 2.53M | 5.35M | 3.86M |
Cash, Cash Equivalents and Short-Term Investments | 271.78K | 951.57K | 1.15M | 1.95M | 1.94M |
Total Debt | 2.84M | 2.40M | 1.35M | 344.42K | 173.93K |
Total Liabilities | 5.74M | 9.49M | 9.69M | 9.48M | 4.52M |
Stockholders Equity | -5.40M | -7.98M | -7.16M | -4.12M | -667.35K |
Cash Flow | |||||
Free Cash Flow | -650.45K | -743.26K | -4.58M | -337.86K | -2.37M |
Operating Cash Flow | -650.45K | -743.26K | -4.58M | -305.03K | -2.37M |
Investing Cash Flow | 0.00 | 0.00 | 0.00 | -32.84K | 0.00 |
Financing Cash Flow | -29.35K | 548.36K | 3.78M | 343.36K | -65.47K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | C$216.35M | ― | -3.13% | 0.43% | -13.99% | -421.95% | |
65 Neutral | C$188.94M | 50.73 | 59.35% | ― | 253.50% | ― | |
64 Neutral | C$648.31M | 29.77 | 27.95% | 3.12% | 19.11% | -15.97% | |
59 Neutral | C$10.08M | 3.65 | -27.82% | ― | 1775.57% | ― | |
52 Neutral | $18.92M | ― | -549.30% | ― | -8.04% | 4.04% | |
50 Neutral | C$3.26B | 5.35 | -49.37% | 9.08% | 2.10% | -13.02% | |
49 Neutral | C$61.56M | ― | -90.88% | ― | 349.56% | -928.83% |
Acceleware Ltd. reported significant financial growth for the year ended December 31, 2024, with revenues increasing substantially compared to the previous year. The company is advancing its RF XL pilot project in Marwayne, Alberta, which aims to decarbonize heavy oil and oil sands production. Despite a temporary shutdown for component upgrades, Acceleware remains confident in the technology’s potential. The company has secured partial funding for the next phase of the project and is actively seeking additional financial support to enhance the commercial viability of its RF XL technology.
Acceleware has announced the grant of stock options for 1,634,000 common shares to select employees, consultants, officers, and directors. The stock options, expiring in 2030 with an exercise price of $0.09 per share, are part of a strategic move to incentivize its team as the company advances its decarbonization technologies across key industrial sectors, subject to regulatory approval.